Across TCGA pan-cancer cohorts, DPEP2NB RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated DPEP2NB data layer.
The strongest signal is observed in adrenocortical carcinoma (ACC), where higher DPEP2NB RNA is associated with worse overall survival. In most high-consensus cancer types, elevated DPEP2NB expression acts as an unfavorable survival marker, although some lineages such as CESC and BLCA show a favorable association.
ACC, READ, and KIRC are the cancer types where DPEP2NB RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.